120 related articles for article (PubMed ID: 29044394)
1. Prediction of cardiovascular risk in patients with familial hypercholesterolaemia.
Villa G; Wong B; Kutikova L; Ray KK; Mata P; Bruckert E
Eur Heart J Qual Care Clin Outcomes; 2017 Oct; 3(4):274-280. PubMed ID: 29044394
[TBL] [Abstract][Full Text] [Related]
2. Risk of cardiovascular disease outcomes in primary care subjects with familial hypercholesterolaemia: A cohort study.
Iyen B; Qureshi N; Kai J; Akyea RK; Leonardi-Bee J; Roderick P; Humphries SE; Weng S
Atherosclerosis; 2019 Aug; 287():8-15. PubMed ID: 31181417
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of Evolocumab in Patients With High Cardiovascular Risk in Spain.
Villa G; Lothgren M; Kutikova L; Lindgren P; Gandra SR; Fonarow GC; Sorio F; Masana L; Bayes-Genis A; Hout BV
Clin Ther; 2017 Apr; 39(4):771-786.e3. PubMed ID: 28366593
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular Disease Risk Associated With Familial Hypercholesterolemia: A Systematic Review of the Literature.
Wong B; Kruse G; Kutikova L; Ray KK; Mata P; Bruckert E
Clin Ther; 2016 Jul; 38(7):1696-709. PubMed ID: 27261205
[TBL] [Abstract][Full Text] [Related]
5. High miR-133a levels in the circulation anticipates presentation of clinical events in familial hypercholesterolaemia patients.
Escate R; Padró T; Suades R; Camino S; Muñiz O; Diaz-Diaz JL; Sionis A; Mata P; Badimon L
Cardiovasc Res; 2021 Jan; 117(1):109-122. PubMed ID: 32061123
[TBL] [Abstract][Full Text] [Related]
6. How to implement clinical guidelines to optimise familial hypercholesterolaemia diagnosis and treatment.
Farnier M; Civeira F; Descamps O;
Atheroscler Suppl; 2017 Apr; 26():25-35. PubMed ID: 28434482
[TBL] [Abstract][Full Text] [Related]
7. The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: data in 2400 patients.
Jansen AC; van Aalst-Cohen ES; Tanck MW; Trip MD; Lansberg PJ; Liem AH; van Lennep HW; Sijbrands EJ; Kastelein JJ
J Intern Med; 2004 Dec; 256(6):482-90. PubMed ID: 15554949
[TBL] [Abstract][Full Text] [Related]
8. Enhanced status of inflammation and endothelial activation in subjects with familial hypercholesterolaemia and their related unaffected family members: a case control study.
Rahman T; Hamzan NS; Mokhsin A; Rahmat R; Ibrahim ZO; Razali R; Thevarajah M; Nawawi H
Lipids Health Dis; 2017 Apr; 16(1):81. PubMed ID: 28438163
[TBL] [Abstract][Full Text] [Related]
9. Knowledge gaps in the management of familial hypercholesterolaemia. A UK based survey.
Schofield J; Kwok S; France M; Capps N; Eatough R; Yadav R; Ray K; Soran H
Atherosclerosis; 2016 Sep; 252():161-165. PubMed ID: 27451004
[TBL] [Abstract][Full Text] [Related]
10. First insights from the EAS familial hypercholesterolaemia collaboration registry: FH is still underdiagnosed and undertreated.
Stock J
Atherosclerosis; 2019 Nov; 290():138-139. PubMed ID: 31610884
[No Abstract] [Full Text] [Related]
11. Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration.
; Vallejo-Vaz AJ; Akram A; Kondapally Seshasai SR; Cole D; Watts GF; Hovingh GK; Kastelein JJ; Mata P; Raal FJ; Santos RD; Soran H; Freiberger T; Abifadel M; Aguilar-Salinas CA; Alnouri F; Alonso R; Al-Rasadi K; Banach M; Bogsrud MP; Bourbon M; Bruckert E; Car J; Ceska R; Corral P; Descamps O; Dieplinger H; Do CT; Durst R; Ezhov MV; Fras Z; Gaita D; Gaspar IM; Genest J; Harada-Shiba M; Jiang L; Kayikcioglu M; Lam CS; Latkovskis G; Laufs U; Liberopoulos E; Lin J; Lin N; Maher V; Majano N; Marais AD; März W; Mirrakhimov E; Miserez AR; Mitchenko O; Nawawi H; Nilsson L; Nordestgaard BG; Paragh G; Petrulioniene Z; Pojskic B; Reiner Ž; Sahebkar A; Santos LE; Schunkert H; Shehab A; Slimane MN; Stoll M; Su TC; Susekov A; Tilney M; Tomlinson B; Tselepis AD; Vohnout B; Widén E; Yamashita S; Catapano AL; Ray KK
Atheroscler Suppl; 2016 Dec; 22():1-32. PubMed ID: 27939304
[TBL] [Abstract][Full Text] [Related]
12. Mutational analysis in UK patients with a clinical diagnosis of familial hypercholesterolaemia: relationship with plasma lipid traits, heart disease risk and utility in relative tracing.
Humphries SE; Cranston T; Allen M; Middleton-Price H; Fernandez MC; Senior V; Hawe E; Iversen A; Wray R; Crook MA; Wierzbicki AS
J Mol Med (Berl); 2006 Mar; 84(3):203-14. PubMed ID: 16389549
[TBL] [Abstract][Full Text] [Related]
13. Differences in characteristics and risk of cardiovascular disease in familial hypercholesterolemia patients with and without tendon xanthomas: a systematic review and meta-analysis.
Oosterveer DM; Versmissen J; Yazdanpanah M; Hamza TH; Sijbrands EJ
Atherosclerosis; 2009 Dec; 207(2):311-7. PubMed ID: 19439299
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular risk stratification in familial hypercholesterolaemia.
Sharifi M; Rakhit RD; Humphries SE; Nair D
Heart; 2016 Jul; 102(13):1003-8. PubMed ID: 27126396
[TBL] [Abstract][Full Text] [Related]
15. Case-finding and genetic testing for familial hypercholesterolaemia in primary care.
Qureshi N; Akyea RK; Dutton B; Humphries SE; Abdul Hamid H; Condon L; Weng SF; Kai J;
Heart; 2021 Dec; 107(24):1956-1961. PubMed ID: 34521694
[TBL] [Abstract][Full Text] [Related]
16. PCSK9 R46L, lower LDL, and cardiovascular disease risk in familial hypercholesterolemia: a cross-sectional cohort study.
Saavedra YG; Dufour R; Davignon J; Baass A
Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2700-5. PubMed ID: 25278291
[TBL] [Abstract][Full Text] [Related]
17. Predictors of cardiovascular events after one year of molecular screening for Familial hypercholesterolemia.
Silva PR; Jannes CE; Marsiglia JD; Krieger JE; Santos RD; Pereira AC
Atherosclerosis; 2016 Jul; 250():144-50. PubMed ID: 27214396
[TBL] [Abstract][Full Text] [Related]
18. Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry.
deGoma EM; Ahmad ZS; O'Brien EC; Kindt I; Shrader P; Newman CB; Pokharel Y; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW
Circ Cardiovasc Genet; 2016 Jun; 9(3):240-9. PubMed ID: 27013694
[TBL] [Abstract][Full Text] [Related]
19. Carotid atherosclerosis and lipoprotein particle subclasses in familial hypercholesterolaemia and familial combined hyperlipidaemia.
Jarauta E; Mateo-Gallego R; Gilabert R; Plana N; Junyent M; de Groot E; Cenarro A; Masana L; Ros E; Civeira F
Nutr Metab Cardiovasc Dis; 2012 Jul; 22(7):591-7. PubMed ID: 21196102
[TBL] [Abstract][Full Text] [Related]
20. Clinical experience of scoring criteria for Familial Hypercholesterolaemia (FH) genetic testing in Wales.
Haralambos K; Whatley SD; Edwards R; Gingell R; Townsend D; Ashfield-Watt P; Lansberg P; Datta DB; McDowell IF
Atherosclerosis; 2015 May; 240(1):190-6. PubMed ID: 25797312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
